Home LiteratureArticle Details
PMID: 25993444 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.

Mucosal immunology ·Vol. 9 ·No. 1 ·2016-01-00 ·Pages 124-36

Schaale K, Peters KM, Murthy AM, Fritzsche AK, Phan MD, Totsika M, Robertson AA, Nichols KB, Cooper MA, Stacey KJ, Ulett GC, Schroder K, Schembri MA, Sweet MJ

Abstract

Uropathogenic Escherichia coli (UPEC) is the main etiological agent of urinary tract infections (UTIs). Little is known about interactions between UPEC and the inflammasome, a key innate immune pathway. Here we show that UPEC strains CFT073 and UTI89 trigger inflammasome activation and lytic cell death in human macrophages. Several other UPEC strains, including two multidrug-resistant ST131 isolates, did not kill macrophages. In mouse macrophages, UTI89 triggered cell death only at a high multiplicity of infection, and CFT073-mediated inflammasome responses were completely NLRP3-dependent. Surprisingly, CFT073- and UTI89-mediated responses only partially depended on NLRP3 in human macrophages. In these cells, NLRP3 was required for interleukin-1β (IL-1β) maturation, but contributed only marginally to cell death. Similarly, caspase-1 inhibition did not block cell death in human macrophages. In keeping with such differences, the pore-forming toxin α-hemolysin mediated a substantial proportion of CFT073-triggered IL-1β secretion in mouse but not human macrophages. There was also a more substantial α-hemolysin-independent cell death response in human vs. mouse macrophages. Thus, in mouse macrophages, CFT073-triggered inflammasome responses are completely NLRP3-dependent, and largely α-hemolysin-dependent. In contrast, UPEC activates an NLRP3-independent cell death pathway and an α-hemolysin-independent IL-1β secretion pathway in human macrophages. This has important implications for understanding UTI in humans.

MeSH Terms
Animals Bacterial Toxins/toxicity Carrier Proteins/genetics,immunology Cell Death/drug effects Gene Expression Regulation Hemolysin Proteins/toxicity Host-Pathogen Interactions Humans Inflammasomes/drug effects,immunology Interleukin-1beta/genetics,immunology Macrophages/drug effects,immunology,microbiology Mice NLR Family, Pyrin Domain-Containing 3 Protein Primary Cell Culture Signal Transduction Species Specificity Uropathogenic Escherichia coli/immunology,pathogenicity
Chemicals
Bacterial Toxins Carrier Proteins Hemolysin Proteins Inflammasomes Interleukin-1beta NLR Family, Pyrin Domain-Containing 3 Protein NLRP3 protein, human Nlrp3 protein, mouse staphylococcal alpha-toxin
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Schaale K
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. | Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
Peters K M
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.
Murthy A M
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia.
Fritzsche A K
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia.
Phan M-D
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.
Totsika M
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
Robertson A A B
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. | Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
Nichols K B
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.
Cooper M A
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. | Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
Stacey K J
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.
Ulett G C
School of Medical Sciences, Griffith Health Institute, Griffith University, Gold Coast, Queensland, Australia.
Schroder K
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. | Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
Schembri M A
Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia. | School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia, Queensland, Australia.
Sweet M J
Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia. | Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
References (56)
56 references, click to expand
  1. Cell death and infection: a double-edged sword for host and pathogen survival.
    J Cell Biol. 2011 Dec 12;195(6):931-42 PMID: 22123830
  2. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.
    Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3076-80 PMID: 20133635
  3. Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence.
    Cell Mol Life Sci. 2014 Mar;71(5):745-70 PMID: 23689588
  4. Genetics of innate immunity and UTI susceptibility.
    Nat Rev Urol. 2011 Jul 12;8(8):449-68 PMID: 21750501
  5. Urine interleukin-1beta in children with acute pyelonephritis and renal scarring.
    Nephrology (Carlton). 2007 Oct;12(5):487-93 PMID: 17803473
  6. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
    PLoS Pathog. 2010 Sep 23;6(9):e1001120 PMID: 20886104
  7. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium.
    Cell. 2014 Jan 30;156(3):456-68 PMID: 24485454
  8. Global dissemination of a multidrug resistant Escherichia coli clone.
    Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9 PMID: 24706808
  9. The epidemiology of urinary tract infection.
    Nat Rev Urol. 2010 Dec;7(12):653-60 PMID: 21139641
  10. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
    Nat Med. 2015 Mar;21(3):248-55 PMID: 25686105
  11. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.
    FEMS Microbiol Lett. 2006 Sep;262(1):22-30 PMID: 16907735
  12. Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection.
    FEMS Microbiol Lett. 2013 Sep;346(1):1-10 PMID: 23808987
  13. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes.
    J Clin Immunol. 2010 Sep;30(5):693-702 PMID: 20490635
  14. Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms.
    PLoS One. 2011;6(10 ):e26578 PMID: 22053197
  15. Involvement of absent in melanoma 2 in inflammasome activation in macrophages infected with Listeria monocytogenes.
    J Immunol. 2010 Jul 15;185(2):1186-95 PMID: 20566831
  16. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    MBio. 2013 Dec 17;4(6):e00377-13 PMID: 24345742
  17. Inflammasome-independent regulation of IL-1-family cytokines.
    Annu Rev Immunol. 2015;33:49-77 PMID: 25493334
  18. The co-transcriptome of uropathogenic Escherichia coli-infected mouse macrophages reveals new insights into host-pathogen interactions.
    Cell Microbiol. 2015 May;17(5):730-46 PMID: 25410299
  19. ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL-1β-dependent manner.
    Mucosal Immunol. 2015 Nov;8(6):1388-99 PMID: 25669147
  20. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
    Immunobiology. 2013 Nov;218(11):1345-53 PMID: 23948647
  21. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.
    Nat Immunol. 2014 Aug;15(8):727-37 PMID: 24952505
  22. Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
    Mediators Inflamm. 2012;2012:381358 PMID: 23319831
  23. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages.
    Cell Microbiol. 2006 Nov;8(11):1812-25 PMID: 16824040
  24. The inflammasomes.
    Cell. 2010 Mar 19;140(6):821-32 PMID: 20303873
  25. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.
    J Immunol. 2011 May 15;186(10 ):5896-906 PMID: 21490151
  26. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious.
    PLoS Pathog. 2011 Dec;7(12 ):e1002452 PMID: 22241982
  27. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection.
    Curr Opin Microbiol. 2013 Jun;16(3):319-26 PMID: 23707339
  28. Sensing and reacting to microbes through the inflammasomes.
    Nat Immunol. 2012 Mar 19;13(4):325-32 PMID: 22430785
  29. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Curr Opin Microbiol. 2013 Feb;16(1):100-7 PMID: 23403118
  30. Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.
    J Immunol. 2010 Jan 15;184(2):922-30 PMID: 20008285
  31. The NLRP3 inflammasome in Alzheimer's disease.
    Mol Neurobiol. 2013 Dec;48(3):875-82 PMID: 23686772
  32. In vivo properties of a cloned K88 adherence antigen determinant.
    Infect Immun. 1986 Apr;52(1):344-7 PMID: 2870029
  33. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing.
    Cell Host Microbe. 2010 Dec 16;8(6):471-83 PMID: 21147462
  34. The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge.
    Cell Rep. 2014 Jul 24;8(2):570-82 PMID: 25043180
  35. Origins and virulence mechanisms of uropathogenic Escherichia coli.
    Exp Mol Pathol. 2008 Aug;85(1):11-9 PMID: 18482721
  36. Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2.
    J Immunol. 2010 Jul 15;185(2):818-21 PMID: 20562263
  37. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.
    Infect Immun. 2005 Jul;73(7):3999-4006 PMID: 15972487
  38. Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.
    PLoS Pathog. 2015 Jan 08;11(1):e1004599 PMID: 25569799
  39. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Infect Immun. 2001 Jul;69(7):4572-9 PMID: 11402001
  40. Differences in the repertoire, regulation and function of Toll-like Receptors and inflammasome-forming Nod-like Receptors between human and mouse.
    Curr Opin Microbiol. 2013 Jun;16(3):303-10 PMID: 23540353
  41. Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria.
    Acta Paediatr Scand. 1975 May;64(3):432-6 PMID: 1098383
  42. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.
    J Clin Invest. 1990 Jun;85(6):1746-53 PMID: 2189890
  43. Noncanonical inflammasome activation by intracellular LPS independent of TLR4.
    Science. 2013 Sep 13;341(6151):1246-9 PMID: 23887873
  44. The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.
    Future Microbiol. 2013 Jan;8(1):73-84 PMID: 23252494
  45. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages.
    Immunity. 2012 Mar 23;36(3):464-76 PMID: 22361007
  46. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Immunobiology. 2011 Nov;216(11):1164-71 PMID: 21802164
  47. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80 PMID: 25675528
  48. Inflammasomes and metabolic disorders: old genes in modern diseases.
    Mol Cell. 2014 Apr 24;54(2):297-308 PMID: 24766894
  49. Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasome.
    Proc Natl Acad Sci U S A. 2014 May 27;111(21):7765-70 PMID: 24828532
  50. Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation.
    J Biol Chem. 2011 Nov 11;286(45):39033-42 PMID: 21930705
  51. Flagellins of Salmonella Typhi and nonpathogenic Escherichia coli are differentially recognized through the NLRC4 pathway in macrophages.
    J Innate Immun. 2014;6(1):47-57 PMID: 23816851
  52. Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome.
    PLoS One. 2012;7(11):e50288 PMID: 23209696
  53. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains.
    Infect Immun. 1990 May;58(5):1281-9 PMID: 2182540
  54. Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells.
    Digestion. 2014;89(2):110-8 PMID: 24503609
  55. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5 PMID: 10829079
  56. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.
    ChemMedChem. 2010 May 3;5(5):730-8 PMID: 20229566
Article Info
Journal
Mucosal immunology
Abbr.
Mucosal Immunol
ISSN
1935-3456
Published
2016-01-00
Epub
2015-00-20
Pages
124-36
Language
English
Region
United States
NLM ID
101299742
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com